138 related articles for article (PubMed ID: 6192225)
1. Quantitative evaluation of functional capacity during isoniazid therapy in Huntington's disease.
Stober T; Schimrigk K; Holzer G; Ziegler B
J Neurol; 1983; 229(4):237-45. PubMed ID: 6192225
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid and Huntington's chorea.
Roccatagliata G; Albano C
N Engl J Med; 1978 Feb; 298(8):457. PubMed ID: 146161
[No Abstract] [Full Text] [Related]
4. Treatment of Huntington's chorea with isoniazid.
Perry TL; MacLeod PM; Hansen S
N Engl J Med; 1977 Oct; 297(15):840. PubMed ID: 142923
[No Abstract] [Full Text] [Related]
5. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
Manyam NV; Hare TA; Katz L
Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
[No Abstract] [Full Text] [Related]
6. Isoniazid and Huntington's chorea.
Perry TL
N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007
[No Abstract] [Full Text] [Related]
7. Isoniazid therapy of Huntington disease.
Perry TL; Wright JM; Hansen S; MacLeod PM
Neurology; 1979 Mar; 29(3):370-5. PubMed ID: 156313
[TBL] [Abstract][Full Text] [Related]
8. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
Perry TL; Wall RA; Hansen S
Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
[TBL] [Abstract][Full Text] [Related]
9. [Symptomatic therapy in a possible animal model for Huntington's chorea].
Schneider G; Oepen H; Klapproth A
Arzneimittelforschung; 1981; 31(3):437-41. PubMed ID: 6452881
[TBL] [Abstract][Full Text] [Related]
10. Hypokinesia in Huntington's disease.
van Vugt JP; van Hilten BJ; Roos RA
Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
Huntington Study Group Reach2HD Investigators
Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
[TBL] [Abstract][Full Text] [Related]
12. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
Manyam BV; Ferraro TN; Hare TA
Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
[TBL] [Abstract][Full Text] [Related]
13. [Cases of Huntington's chorea observed in a psychiatric setting: remarks on therapy].
Biéder J
Ann Med Psychol (Paris); 1975 Oct; 2(3):589-92. PubMed ID: 129019
[No Abstract] [Full Text] [Related]
14. Isoniazid therapy for Huntington disease.
Braham J
Neurology; 1981 Dec; 31(12):1580-1. PubMed ID: 6458778
[No Abstract] [Full Text] [Related]
15. Failure of isoniazid therapy in Huntington disease.
McLean DR
Neurology; 1982 Oct; 32(10):1189-91. PubMed ID: 6214730
[No Abstract] [Full Text] [Related]
16. [Westphal's variant of Huntington's chorea].
MACKENZIE-VAN DER NOORDAA MC
Ned Tijdschr Geneeskd; 1960 Aug; 104():1625-7. PubMed ID: 13764916
[No Abstract] [Full Text] [Related]
17. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
Alpay M; Koroshetz WJ
Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
[TBL] [Abstract][Full Text] [Related]
18. Huntington's dementia. Clinical and neuropsychological features.
Caine ED; Hunt RD; Weingartner H; Ebert MH
Arch Gen Psychiatry; 1978 Mar; 35(3):377-84. PubMed ID: 153122
[TBL] [Abstract][Full Text] [Related]
19. A double-blind clinical trial of isoniazid in Huntington disease.
Perry TL; Wright JM; Hansen S; Thomas SM; Allan BM; Baird PA; Diewold PA
Neurology; 1982 Apr; 32(4):354-8. PubMed ID: 6460947
[TBL] [Abstract][Full Text] [Related]
20. Correlates of early disability in Huntington's disease.
Mayeux R; Stern Y; Herman A; Greenbaum L; Fahn S
Ann Neurol; 1986 Dec; 20(6):727-31. PubMed ID: 2949692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
